JPMORGAN CHASE & CO - 30 Sep 2025 SCHEDULE 13G/A Report for Karyopharm Therapeutics Inc. Common Stock, $0.0001 par value (KPTI)
- Filing Manager
- JPMORGAN CHASE & CO
- Reporting Manager
- JPMORGAN CHASE & CO.
- Symbol
- KPTI
- Shares outstanding
- 8,727,020 shares
- Disclosed Ownership
- 427,624 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Oct 2025, 13:55:35 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 16 Jul 2025
- SEC
- View on sec.gov
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO. | 4.9% | 427,624 | 427,624 | 0 | Rachel Tsvaygoft | Vice President |